Aspirin

Aspirin Use Found to Prevent Cholangiocarcinoma

Aspirin Use Found to Prevent Cholangiocarcinoma

By

Aspirin's anti-inflammatory action is protective against another aggressive cancer: cholangiocarcinoma. Furthermore, it is beneficial regardless of daily use or dose.

Anticancer Properties of Salicylic Acid and Diflunisal Revealed in Laboratory Experiments

Anticancer Properties of Salicylic Acid and Diflunisal Revealed in Laboratory Experiments

By

Researchers revealed a pathway in cell culture and mice by which salicylic acid decreases inflammation and by which salicylic acid and diflunisal decrease cancerous growth.

Evidence Mounts That Low-Dose Aspirin Improves Survival in CRC

Evidence Mounts That Low-Dose Aspirin Improves Survival in CRC

Greatest survival benefit observed for those taking the drug before their cancer diagnosis.

Low-dose Aspirin Appears to Improve Cancer Survival and Metastasis

Low-dose Aspirin Appears to Improve Cancer Survival and Metastasis

By

A low-dose of aspirin could increase survival by up to 20% and help stop metastasis for patients receiving cancer treatment.

USPSTF Releases Updated Recommendations for Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer

USPSTF Releases Updated Recommendations for Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer

By

The US Preventive Services Task Force (USPSTF) updated its recommendations on low-dose aspirin use for the primary prevention of CVD and the use of aspirin and NSAIDs for prevention of CRC.

Regular Aspirin Use Could Reduce Colorectal, Gastrointestinal, and Overall Cancer Risks

Regular Aspirin Use Could Reduce Colorectal, Gastrointestinal, and Overall Cancer Risks

By

Regular, low doses of aspirin for a minimum of 6 years correlated with a small, yet significant reduction in overall cancer risk, due primarily to reductions in risks for colorectal cancer and gastrointestinal cancer.

Daily Low-Dose Aspirin May Reduce Risk of Some Cancers

Daily Low-Dose Aspirin May Reduce Risk of Some Cancers

The anti-cancer effect of low-dose aspirin was seen most strongly with colon and gastrointestinal tumors.

Lethal Prostate Cancer Risk Lower With Regular Aspirin Use

Lethal Prostate Cancer Risk Lower With Regular Aspirin Use

By

The risk of lethal prostate cancer, but not of overall, high-grade, or advanced cancers, was reduced with regular aspirin use.

Postdiagnosis Aspirin Improves Survival in All Gastrointestinal Cancers

Postdiagnosis Aspirin Improves Survival in All Gastrointestinal Cancers

By

Aspirin improves survival in patients with tumors situated throughout the gastrointestinal (GI) tract, according to results from a large study. This is the first time that survival data from patients with tumors in different GI locations have been analyzed at the same time.

Aspirin reverses obesity cancer risk

Aspirin reverses obesity cancer risk

By

A regular regimen of aspirin can reduce additional cancer risk for obese individuals, according to study data.

Low-dose aspirin may lessen colorectal cancer risk

Low-dose aspirin may lessen colorectal cancer risk

Regular aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may lower the long-term risk of colorectal cancer (CRC), new study data suggests.

Aspirin may reduce elevated risk of cancer caused by obesity

Aspirin may reduce elevated risk of cancer caused by obesity

Taking aspirin regularly can negate the increased the risk for developing colorectal cancer in patients with Lynch syndrome.

Aspirin Exposure after Colorectal Cancer Diagnosis Associated with Improved Survival

Aspirin Exposure after Colorectal Cancer Diagnosis Associated with Improved Survival

By

Aspirin exposure after a colorectal cancer diagnosis was independently associated with improved colorectal cancer-specific survival.

Aspirin use does not reduce prostate cancer mortality

Aspirin use does not reduce prostate cancer mortality

Post-diagnostic aspirin use is not associated with a decreased risk of prostate cancer outcomes, according to study data.

AACR: Regular aspirin use associated with decreased GI cancer risk

AACR: Regular aspirin use associated with decreased GI cancer risk

Taking aspirin regularly may help prevent gastrointestinal cancers, a new study suggests, with the greater benefit seen when taking it over many years.

Over 10% of cardiology practice patients inappropriately take aspirin

Over 10% of cardiology practice patients inappropriately take aspirin

More than 10% of patients are inappropriately taking aspirin for primary prevention of cardiovascular disease.

Aspirin and/or NSAID use may improve risk of high-grade prostate cancer

Aspirin and/or NSAID use may improve risk of high-grade prostate cancer

A recent meta-analysis demonstrated an association between aspirin and a reduced risk of prostate cancer.

Daily aspirin may lower mortality in nonmetastatic prostate cancer

Daily aspirin may lower mortality in nonmetastatic prostate cancer

Even a small daily dose of aspirin may help lower mortality among men with nonmetastatic prostate cancer, according to research.

Aspirin may decrease the risk for developing high-grade prostate cancer

Aspirin may decrease the risk for developing high-grade prostate cancer

Aspirin and other other NSAIDs were associated with a decreased risk for developing an aggressive form of prostate cancer.

NSAIDs may lower breast cancer recurrence in overweight and obese women

By

Recurrence of hormone-related breast cancer was reduced by 50% in overweight and obese women who regularly used aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs), according to newly published data.

Prophylactic aspirin may aid cancer prevention

Prophylactic aspirin may aid cancer prevention

Daily aspirin appears beneficial for men and women between ages 50 and 65 in the general population.

Daily dose of aspirin significant lowers cancer risk

Daily dose of aspirin significant lowers cancer risk

In a recent study, researchers found that by taking a daily aspirin, the incidence of gastrointestinal cancers is reduced, as well as a reduction in cancer-specific mortality.

Study finds aspirin may reduce cancer risk, but it's not for everyone

Study finds aspirin may reduce cancer risk, but it's not for everyone

Guidelines from the Fred Hutchinson Cancer Research Center advise that low-dose daily aspirin for prevention of pancreatic cancer may not be for everyone.

Aspirin and smoking influence aging processes connected to cancer

Aspirin and smoking influence aging processes connected to cancer

Researchers from the University of Basel were able to show that aspirin use and smoking both influence aging processes of the female genome that are connected to colorectal cancer.

Daily aspirin may ward off pancreatic cancer

Daily aspirin may ward off pancreatic cancer

People who take low-dose aspirin for more than 10 years might be reducing their risk for pancreatic cancer, a new study suggests.

Aspirin may reduce colorectal cancer risk for some people

Aspirin may reduce colorectal cancer risk for some people

By

Aspirin may have just added another beneficial effect beyond its ability to ameliorate headaches and reduce heart attack risk: it lowers risk for colon cancer among people with high levels of a specific type of gene.

Aspirin use lowers CRC risk with high <i>15-PGDH</i> expression

Aspirin use lowers CRC risk with high 15-PGDH expression

Regular aspirin use is associated with a reduced risk of colorectal cancer in association with high hydroxyprostaglandin dehydrogenase 15-(nicotinamide adenine dinucleotide) (15-PGDH) expression.

Aspirin linked to improved survival after colon cancer diagnosis

Aspirin linked to improved survival after colon cancer diagnosis

By

Taking low doses of aspirin, which inhibits platelet function, after a colon cancer diagnosis appears to be associated with better survival if the tumor cells express HLA class I antigen.

Daily aspirin may lower ovarian cancer risk

Daily aspirin may lower ovarian cancer risk

A study of almost 20,000 women found the drug lowered ovarian cancer risk by 20 percent.

How aspirin improves survival in colon cancer

By

Aspirin improves outcomes in patients whose tumor cells express a specific protein on their surface that is known as human leukocyte antigen class I (HLA class I), according to research.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs